Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalNo recent work listed

Xue Ling Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-7724-7632; OpenAlex author ID A5068805735. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper

Papers 3

  1. Ultrasound combined with computed tomography in pancreatic cancer. Last author PMID 31646809↗
  2. Paeoniflorin Potentiates the Inhibitory Effects of Erlotinib in Pancreatic Cancer Cell Lines by Reducing ErbB3 Phosphorylation. First author DOI 10.1038/srep32809↗
  3. Survival Benefits of Western and Traditional Chinese Medicine Treatment for Patients With Pancreatic Cancer. Co-author DOI 10.1097/md.0000000000001008↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jian Hao · 2 shared papers, 2015–2016 · strength 0.12
  2. Xiong-Zhi Wu · 2 shared papers, 2015–2016 · strength 0.12
  3. Lei Liu · 1 shared paper, 2019 · strength 0.11
  4. Tong Zhou · 1 shared paper, 2016 · strength 0.06
  5. Chang Liu · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.